Author/Authors :
Magano، نويسنده , , Javier and Farrand، نويسنده , , Douglas and Haase، نويسنده , , Jeffrey P. and Lovdahl، نويسنده , , Michael T. Maloney، نويسنده , , Mark T. and Pozzo، نويسنده , , Mark J. and Teixeira، نويسنده , , John J. and Whritenour، نويسنده , , David C. and Rizzo، نويسنده , , John and Tumelty، نويسنده , , David and Bhat، نويسنده , , Abhijit and Bradshaw، نويسنده , , Curt، نويسنده ,
Abstract :
An optimized and scalable synthesis of a novel analytical reagent for the determination of the number of active sites available for conjugation on a catalytic aldolase monoclonal antibody (mAb) is described. The original conditions suffered from lack of reproducibility, incomplete reactions, and required several chromatographies and lyophilizations that afforded material of low purity. A redesigned route and optimized protocols have been developed that eliminate the use of toxic and unsafe reagents such as HMPA and HATU. In addition, the number of chromatographies has been reduced to only one and time-consuming and energy-intensive lyophilizations are no longer required. The overall yield has been considerably improved from the original 4% to 20% after telescoping the last two steps of the synthesis and this new approach allowed for the preparation of material with higher chemical purity (⩾99% vs the initial 90%) to meet specifications.
Keywords :
Bioconjugation , Analytical reagent , Biopharmaceuticals , Enaminone